Your session is about to expire
← Back to Search
Ketamine Imaging for Mood Disorders
Study Summary
This trial is designed to study the effects of ketamine on synaptic density in people with depression or PTSD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 18 and 70 years old.You understand that this study is solely for research purposes and not for medical treatment.You do not have any current or past mental health conditions as defined by the DSM-5.I have been diagnosed with bipolar disorder according to DSM-5.I have never had a major brain condition, injury, or long-term memory loss.I cannot have a PET scan due to past cancer or issues with my veins.I have been diagnosed with major depression or PTSD with psychotic features.I weigh less than 110 lbs.I am currently diagnosed with PTSD.I am between 18 and 70 years old, speak English, and have no mental health diagnoses except as specified.I am diagnosed with Major Depressive Disorder and currently receiving ketamine treatment.You do not have any other mental health conditions, except for the ones listed below.I am currently diagnosed with PTSD.I have a bleeding disorder or am currently on blood thinners.
- Group 1: PET scans for subjects undergoing ketamine treatment
- Group 2: PET scans and ketamine administration
- Group 3: Single PET scan
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent is enrollment being pursued for this clinical trial?
"Affirmative. Clinicaltrials.gov has evidence that this medical investigation, which was first publicized on April 1st 2016, is currently recruiting members for the trial. 30 patients must be enrolled from a single study site."
Who meets the eligibility criteria to be involved in this clinical trial?
"This medical experiment is looking for 30 individuals with a diagnosis of mood disorder between the ages 18 and 70. Notably, applicants must have no current or past DSM-5 disorders, be treatment seeking aware that this study serves research purposes only and possess a Post Traumatic Stress Disorder (PTSD)."
Are there any vacancies in this clinical trial for participants?
"Clinicaltrials.gov indicates that this clinical trial is in the recruitment phase, which it entered when first posted on April 1st 2016 and was most recently updated on April 13th 2022."
Does the age of 50 constitute a barrier to entry for this experiment?
"The requirements for patient inclusion in this trial are 18 years of age as the lower limit and 70 as the upper age limit."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger